Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2004;43:224-228
Published online before print December 22, 2003, doi: 10.1161/01.HYP.0000109319.63240.08
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/2/224    most recent
01.HYP.0000109319.63240.08v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franks, P. W.
Right arrow Articles by Wareham, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franks, P. W.
Right arrow Articles by Wareham, N. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
Medline Plus Health Information
*Exercise for Children
*Exercise and Physical Fitness
Related Collections
Right arrow Clinical genetics
Right arrow Exercise/exercise testing/rehabilitation
Right arrow Epidemiology

(Hypertension. 2004;43:224.)
© 2004 American Heart Association, Inc.


Scientific Contributions

Association Between Physical Activity and Blood Pressure Is Modified by Variants in the G-Protein Coupled Receptor 10

Paul W. Franks; Sumit Bhattacharyya; Jian’an Luan; Carl Montague; John Brennand; Benjamin Challis; Søren Brage; Ulf Ekelund; Rita P.S. Middelberg; Stephen O’Rahilly; Nicholas J. Wareham

From the University of Cambridge, Departments of Public Health and Primary Care (P.W.F., J.L., S.B., U.E., R.P.S.M., N.J.W.), Medicine (S.B., B.C., S.O.), and Clinical Biochemistry (S.O.), Cambridge, UK, and the CVGI Discovery Department (C.M., J.B.), Astra Zeneca Pharmaceuticals, UK.

Correspondence to Dr Nicholas J. Wareham, Director, MRC Epidemiology Unit, Strangeways Research Laboratory, Worts Causeway, Cambridge CB1 8RN. UK. E-mail njw1004{at}medschl.cam.ac.uk

Hypertension is strongly related to cardiovascular disease and all-cause mortality. Exercise reduces blood pressure but the response varies between individuals. The mechanisms by which physical activity energy expenditure (PAEE) modifies blood pressure are not fully defined but include modulation of sympathetic tone. Novel polymorphisms in the G-protein coupled receptor (GPR10) have been linked with high blood pressure. GPR10 may mediate the relationship between PAEE and blood pressure via central nervous mechanisms. We examined whether two GPR10 polymorphisms (G-62A and C914T) modify the association between PAEE and blood pressure in the MRC Ely study (N=687). When stratified by the C914T genotype, there were between-group differences for body mass index (BMI) (P=0.05), diastolic blood pressure (DBP) (P=0.006), and systolic blood pressure (SBP) (P=0.005). No differences were found between G-62A genotypes. The previously reported inverse relationship between PAEE and blood pressure was not observed in minor allele carriers for either polymorphism (A62 carriers: DBP ß-1.11, P=0.52; SBP ß-1.66, P=0.52. T914 carriers: SBP ß=3.27; P=0.60) but was in common allele homozygotes (G62G: DBP ß-6.18 P=0.00001; SBP ß-8.54 P=0.0001. C914C: SBP ß-7.07; P=0.00001). This corresponded to a significant interaction between PAEE and GPR10 polymorphisms on DBP (G-62A: P=0.006) and SBP (G-62A: P=0.008. C914T: P=0.068). Significant interactions were observed between haplotype (derived from G-62A and C914T), PAEE, and blood pressure (DBP: P=0.08; SBP: P=0.023). The effect of physical activity on blood pressure is highly variable at population level. Knowledge of GPR10 genotype may define those who are least likely to benefit from physical activity. These findings may have relevance in the targeted treatment of hypertensive disease.


Key Words: exercise • epidemiology • blood pressure • genetics




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
K. S. Vimaleswaran, J. Luan, G. Andersen, Y. L. Muller, E. Wheeler, E. C. Brito, S. O'Rahilly, O. Pedersen, L. J. Baier, W. C. Knowler, et al.
The Gly482Ser genotype at the PPARGC1A gene and elevated blood pressure: a meta-analysis involving 13,949 individuals
J Appl Physiol, October 1, 2008; 105(4): 1352 - 1358.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
P. W. Franks, W. C. Knowler, S. Nair, J. Koska, Y.-H. Lee, R. S. Lindsay, B. R. Walker, H. C. Looker, P. A. Permana, P. A. Tataranni, et al.
Interaction Between an 11{beta}HSD1 Gene Variant and Birth Era Modifies the Risk of Hypertension in Pima Indians
Hypertension, November 1, 2004; 44(5): 681 - 688.
[Abstract] [Full Text] [PDF]